at June 30, 2018, the consolidated debt to equity ratio was 0.45 time and the consolidated net debt to equity ratio was considerably low at 0.30 time. Financial Highlights 2Q 2018 2Q 2017 Change 6M
2016 Year 2015 increase (decrease) Million Baht % Million Baht % Million Baht % Revenue Revenue from immovable property sales 708.62 89.23% 919.19 98.12% -210.57 -22.91% Other income 85.57 10.77% 17.60
sales expenses (excluding ownership transfer expenses) increase 46.18% as a result of the brokerage fee from the recognized income of 25.62 million THB of Lumpini Suite Petchaburi - Makkasan. Main income
1H/ 2017, accounted for 22.85% increase due to the introduction of 9 new branches compared to the same period last year. The Group had other revenues of THB 5.61 million in 1H/ 2018 which increased
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
Deduct Minority interest - - Net tangible assets (NTA) 604.68 (0.22) Plus Capital increase from ex-shareholder :At-Ze prior to share sale and purchase date* - 30.00 Net tangible assets (NTA)-adjusted
Intangible assets deduct 11.53 0.54 Deduct Total liabilities 315.37 157.34 Deduct Minority interest - - Net tangible assets (NTA) 604.68 (0.22) Plus Capital increase from ex-shareholder :At-Ze prior to share
% growth of revenue from sales of house and condominium units and 71% increase in revenue from rental and services attributed to the rise of total revenue. 2Q19 Net profit at THB 192m, or 56% decline YoY
usage of purchasing raw materials in order to reduce loan interest Other non-current financial assets decreased of 42.63 Million Baht due to closure of equity funds and in the process of accepting